23 May 2013
Keywords: fibrogen, fg-4539, reduces, brain, tissue, damage, ischemic
Article | 27 February 2006
Florida, USA-based FibroGen has said that a single dose of FG-4539, its novel small-molecule inhibitor of hypoxia-inducible factor (HIF) prolyl
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 February 2006
22 May 2013
© 2013 thepharmaletter.com